Showing 1 - 10 of 657,654
Persistent link: https://www.econbiz.de/10003823695
Persistent link: https://www.econbiz.de/10013387083
Persistent link: https://www.econbiz.de/10010225259
Persistent link: https://www.econbiz.de/10002638729
We develop a model of pandemic risk management and firm valuation. We introduce aggregate transmission shocks into an epidemic model and link valuations to infections via an asset-pricing framework with vaccines. Infections lower earnings growth but firms can mitigate damages. We estimate a...
Persistent link: https://www.econbiz.de/10012833123
We develop a model of pandemic risk management and firm valuation. We introduce aggregate transmission shocks into an epidemic model and link valuations to infections by using an asset-pricing framework that accounts for vaccines. Infections lower earnings growth but firms can mitigate damages....
Persistent link: https://www.econbiz.de/10012834259
Persistent link: https://www.econbiz.de/10012616319
Persistent link: https://www.econbiz.de/10013252945
Persistent link: https://www.econbiz.de/10010217827
We develop a model of pandemic risk management and firm valuation. We introduce aggregate transmission shocks into an epidemic model and link valuations to infections via an asset-pricing framework with vaccines. Infections lower earnings growth but firms can mitigate damages. We estimate a...
Persistent link: https://www.econbiz.de/10012481801